Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Peroxisomal Biogenesis Factor 5 (PEX5) (Middle Region) Peptid

PEX5 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN981605

Kurzübersicht für Peroxisomal Biogenesis Factor 5 (PEX5) (Middle Region) Peptid (ABIN981605)

Target

PEX5 (Peroxisomal Biogenesis Factor 5 (PEX5))

Spezies

Human

Quelle

  • 5
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-PEX5 antibody (Catalog #: ARP56102_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    PEX5 (Peroxisomal Biogenesis Factor 5 (PEX5))

    Hintergrund

    PEX5 binds to the C-terminal PTS1-type tripeptide peroxisomal targeting signal (SKL-type) and plays an essential role in peroxisomal protein import. Peroxins (PEXs) are proteins that are essential for the assembly of functional peroxisomes. The peroxisome biogenesis disorders (PBDs) are a group of genetically heterogeneous autosomal recessive, lethal diseases characterized by multiple defects in peroxisome function. The peroxisomal biogenesis disorders are a heterogeneous group with at least 14 complementation groups and with more than 1 phenotype being observed in cases falling into particular complementation groups. Although the clinical features of PBD patients vary, cells from all PBD patients exhibit a defect in the import of one or more classes of peroxisomal matrix proteins into the organelle. Defects in this gene are a cause of neonatal adrenoleukodystrophy (NALD), a cause of Zellweger syndrome (ZWS) as well as may be a cause of infantile Refsum disease (IRD).

    Alias Symbols: PTS1R, PXR1, PTS1-BP

    Protein Interaction Partner: PEX12,PEX14,AGXT,ATM,DDO,HSPA1A,PDZK1,PEX10,PEX12,PEX13,PEX14,PEX7,SCARB1,SIRT3,SNUPN,SSTR5,ATM,CAT,DDO,PDZK1,PEX10,PEX12,PEX13,PEX14,PEX7,SIRT3,SNUPN

    Protein Size: 631

    Molekulargewicht

    70 kDa

    Gen-ID

    5830

    NCBI Accession

    NM_000319, NP_000310
Sie sind hier:
Chat with us!